Mikael Cohen

A prospective observational post‐marketing study of natalizumab‐treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort

P. Vermersch, M. Clanet, B. Brochet, 2014, European journal of neurology.